General Information of This Linker
Linker ID
LIN0NNNNA
Linker Name
WO2024043319A1 Linker 17
Linker Type
Cathepsin-cleavable linker
Antibody-Linker Relation
Cleavable
Structure
Formula
C36H39N5O9S2
Isosmiles
O=C(NCC(NCC(N[C@@H](CC1=CC=CC=C1)C(NCC(O)=O)=O)=O)=O)CCOCCN2C(C(SC3=CC=CC=C3)C(SC4=CC=CC=C4)C2=O)=O
InChI
InChI=1S/C36H39N5O9S2/c42-28(37-21-29(43)38-22-30(44)40-27(34(47)39-23-31(45)46)20-24-10-4-1-5-11-24)16-18-50-19-17-41-35(48)32(51-25-12-6-2-7-13-25)33(36(41)49)52-26-14-8-3-9-15-26/h1-15,27,32-33H,16-23H2,(H,37,42)(H,38,43)(H,39,47)(H,40,44)(H,45,46)/t27-,32?,33?/m0/s1
InChIKey
ILHKVWQFALSSOG-BECFNDGMSA-N
Pharmaceutical Properties
Molecule Weight
749.868
Polar area
200.31
Complexity
1572.30591
xlogp Value
1.2444
Heavy Count
52
Rot Bonds
20
Hbond acc
10
Hbond Donor
5
Each Antibody-drug Conjugate Related to This Linker
Full Information of The Activity Data of The ADC(s) Related to This Linker
WO2024043319A1 17 [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
0.04 nM
Positive CEACAM6_#84.7 expression (CEACAM6_#84.7 +++/++)
Method Description
In vitro cytotoxicity of ADCs in AsPC-1 cells.
In Vitro Model Pancreatic ductal adenocarcinoma AsPC-1 cells CVCL_0152
References
Ref 1 Antibody-drug complexes